Generic Drug Application Submission Downturn Continued In June
Executive Summary
Approvals also plummeted, but US FDA remains on a record-breaking pace.
You may also be interested in...
December ANDA Rush Is Largest In Two Years
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
December ANDA Rush Is Largest Monthly Haul In Two Years
However, the month may be losing its influence over the US FDA's annual submission total.
US Approvals Off To A Slow Start
US FDA reports another low tally of full approvals in October, but stakeholders are not worried given the agency's history of record-breaking totals year over year.